Robert T. Bailer

Active 1986–2025

Also published as
Robert T Bailer
99
Papers
22,483
Citations
84
h-index
97
i10-index

Citations

Citations per year for Robert T. Bailer1987: 1 citations1988: 4 citations1989: 4 citations1990: 1 citations1991: 2 citations1992: 7 citations1993: 8 citations1995: 3 citations1998: 1 citations1999: 2 citations2000: 5 citations2001: 16 citations2002: 10 citations2003: 12 citations2004: 6 citations2005: 7 citations2006: 23 citations2007: 35 citations2008: 78 citations2009: 34 citations2010: 84 citations2011: 87 citations2012: 77 citations2013: 166 citations2014: 236 citations2015: 362 citations2016: 415 citations2017: 460 citations2018: 455 citations2019: 1,222 citations2020: 1,329 citations2021: 1,050 citations2022: 680 citations2023: 493 citations2024: 731 citations2025: 355 citations2026: 4 citations1994: no citations, so this year is not shown1996–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,761 citing papers, 38.7% of this breakdownUnited Kingdom: 493 citing papers, 6.9% of this breakdownChina: 356 citing papers, 5% of this breakdownGermany: 276 citing papers, 3.9% of this breakdownNetherlands: 267 citing papers, 3.7% of this breakdownFrance: 227 citing papers, 3.2% of this breakdownSouth Africa: 205 citing papers, 2.9% of this breakdownCanada: 204 citing papers, 2.9% of this breakdownAustralia: 184 citing papers, 2.6% of this breakdownSwitzerland: 175 citing papers, 2.4% of this breakdownItaly: 148 citing papers, 2.1% of this breakdownIndia: 122 citing papers, 1.7% of this breakdown
0%38.7%Other 24%

Fields

  • Medicine48.3%
  • Immunology and Microbiology38.6%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Agricultural and Biological Sciences0.6%
  • Environmental Science0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Other1.6%

Topics

  • HIV Research and Treatment12%
  • SARS-CoV-2 and COVID-19 Research5.6%
  • Immune Cell Function and Interaction5.6%
  • Monoclonal and Polyclonal Antibodies Research5.4%
  • vaccines and immunoinformatics approaches4.2%
  • Immunotherapy and Immune Responses3.9%
  • Other63.3%

Coauthors

All papers

Open in search
  1. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kwanyee Leung, Wing‐Pui Kong, Alec W. Freyn, Raffael Nachbagauer, Peter Palese, Robert T. Bailer, Adrian B. McDermott, Richard A. Koup, Jason G. Gall, Frank Arnold, John R. Mascola, Barney S. Graham, Julie E. Ledgerwood, the VRC 316 Study Team, Joseph P. Casazza, LaSonji A. Holman, Abidemi O. Ola, Pamela Costner, Jennifer Cunningham, Brenda Larkin, Laura Novik, Jamie Saunders, William Whalen, Xiaolin Wang, Aba Mensima Eshun, Alison Taylor, K.-C. Cheng, Carolyn M. Laurençot, Josephine H. Cox, Sandra Sitar, Lam Le, Iris Pittman, Olga Vasilenko, Ro Shauna Rothwell, Galina V. Yamshchikov, Eugenia Burch, Somia P. Hickman, Olga Trofymenko, Catina Boyd, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Zana Blaku, Colin Tran - Nature Medicine 2022 cited by 163

  2. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

    Authors: , , , , , , , , , , , - Journal of Immunological Methods 2013 cited by 585

  3. Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Seaman, Lawrence Shapiro, John R. Mascola, Peter D. Kwong, Mark Connors - Immunity 2016 cited by 395

  4. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barney S. Graham, Susan Moir, Richard A. Koup, John R. Mascola, James A. Hoxie, Anthony S. Fauci, Pablo Tebas, Tae‐Wook Chun - New England Journal of Medicine 2016 cited by 475

  5. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip W. Berman, Nicole Frahm, Stephen C. De Rosa, Michael D. Alpert, Nicole L. Yates, Xiaoying Shen, Richard A. Koup, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Nelson L. Michael, Jérôme H. Kim - New England Journal of Medicine 2012 cited by 1,834

  6. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yaroslav Tsybovsky, Ulrich Baxa, James C. Mullikin, Kanta Subbarao, Daniel C. Douek, Barney S. Graham, Richard A. Koup, Julie E. Ledgerwood, Mario Roederer, Lawrence Shapiro, Peter D. Kwong, John R. Mascola, Adrian B. McDermott - Cell 2016 cited by 359

  7. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 852

  8. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martha Sedegah, Awalludin Sutamihardja, Gary A. Fahle, Kirsten E. Lyke, Matthew B. Laurens, Mario Roederer, Kavita Tewari, Judith E. Epstein, B. Kim Lee Sim, Julie E. Ledgerwood, Barney S. Graham, Stephen L. Hoffman, the VRC 312 Study Team, Cassandra DiGiovanni, Pernell Williams, Nicole Luongo, Jillian Mitchell, Maria Burgos Florez, Brenda Larkin, Nina M. Berkowitz, Brandon Wilson, Tanya Clarke, Olga Vasilenko, Galina V. Yamshchikov, Sandra Sitar, LaChonne Stanford, Iris Pittman, Robert T. Bailer, Joseph P. Casazza, Hope DeCederfelt, Judith Starling, Esther C. Williams, Anna F. Lau, Stella Antonara, Jeffery Brocious, Margaret A. Kemp, James Inglese, Patricia Dranchak, Esteban Abot, Sharina Reyes, Harini Ganeshan, María Belmonte, Jun Huang, Arnel Belmonte, Jack Komisar, Yonas Abebe, Yeab Getachew, Asha Patil, Steve Matheny, K. E. Nelson, James Overby, Virak Pich, Yingda Wen, Richard Fan, Enni Fomumbod, Aderonke Awe, Chinnamma Chakiath, Mary D. King, Maria Socorro Orozco, Tooba Murshedkar, Debbie Padilla, Bing Jiang, Lixin Gao, Natasha KC, Rui Xu, Matthew Adams, Christopher V. Plowe, Hayley Loblein, Phyllis Renehan, Meghan Kunchai and 1 more - Science 2013 cited by 784

  9. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yongping Yang, Zhenhai Zhang, NISC Comparative Sequencing, James C. Mullikin, James Μ. Binley, Rogier W. Sanders, Ian A. Wilson, John P. Moore, Andrew C. Ward, George Georgiou, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, Peter D. Kwong, Lawrence Shapiro, John R. Mascola - Nature 2014 cited by 756

  10. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2018 cited by 253

  11. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Stuckey, Paul V. Thomas, Tishina Tittley, Constance Williams, Baoshan Zhang, Hong Zhao, Zhou Zhou, Bruce R. Donald, Lawrence K. Lee, Susan Zolla‐Pazner, Ulrich Baxa, Arne Schön, Ernesto Freire, Lawrence Shapiro, Kelly K. Lee, James Arthos, James B. Munro, Scott C. Blanchard, Walther Mothes, James Μ. Binley, Adrian B. McDermott, John R. Mascola, Peter D. Kwong - Nature Structural & Molecular Biology 2015 cited by 368

  12. Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Virology 2013 cited by 363

  13. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Koup, Daniel C. Douek, Zonghui Hu, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, VRC 601 Study Team - Science Translational Medicine 2015 cited by 479

  14. Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature, Nat. 2014 cited by 779

  15. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yen‐Ting Lai, Thomas Lemmin, Krisha McKee, Tiffany Y. Ohr, Li Ou, Dongjun Peng, Ariana P. Rowshan, Zizhang Sheng, John-Paul Todd, Yaroslav Tsybovsky, Elise G. Viox, Yiran Wang, Hui Wei, Yongping Yang, Amy F. Zhou, Rui Chen, Lu Yang, Diana G. Scorpio, Adrian B. McDermott, Lawrence Shapiro, Bridget Carragher, Clinton S. Potter, John R. Mascola, Peter D. Kwong - Nature Medicine 2018 cited by 310

  16. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hung‐Pin Peng, An‐Suei Yang, James C. Mullikin, Matthew D. Gray, Leonidas Stamatatos, Dennis R. Burton, Wayne C. Koff, Myron S. Cohen, Barton F. Haynes, Joseph P. Casazza, Mark Connors, Davide Corti, Antonio Lanzavecchia, Quentin J. Sattentau, Robin A. Weiss, Anthony P. West, Pamela J. Björkman, Johannes F. Scheid, Michel C. Nussenzweig, Lawrence Shapiro, John R. Mascola, Peter D. Kwong - Cell 2015 cited by 340

  17. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynn Morris, John R. Mascola - Journal of Virology 2015 cited by 261

  18. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. Montefiori, Ashley M. Trama, Hua‐Xin Liao, Thomas B. Kepler, M. Anthony Moody, Feng Gao, Samuel J. Danishefsky, John R. Mascola, George M. Shaw, Beatrice H. Hahn, Stephen C. Harrison, Bette Korber, Barton F. Haynes - Science Translational Medicine 2017 cited by 290

  19. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Connors, Andrew B. Ward, Peter D. Kwong, John R. Mascola - Science 2016 cited by 377

  20. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barney S. Graham, Theodore C. Pierson, Julie E. Ledgerwood, Grace Chen, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham, Olga Vasilenko, Maria Burgos Florez, Somia P. Hickman, Iris Pittman, Lam Le, Brenda Larkin, Charla Andrews, Preeti Apte, Renunda Hicks, Cora Trelles Cartagena, Pernell Williams, Catina Boyd, Michelle Conan-Cibotti, Judy Stein, Florence Kaltovich, Hope DeCederfelt, Stacey McAdams, Phyllis Renehan, Wilbur Chen, Nancy Greenberg, Nancy Wymer, Linda Wadsworth, Melissa Billington, Toni Robinson, Colleen Boyce, Faith Pa'ahana Brown, Lisa Chrisley, Alyson Kwon, Prashant Patel, Panagoita Kominou, Brenda Dorsey, Staci Eddington, Shinyi Telscher, Myoughee Lee, Regina Mosely, April Ross, Geoffrey Ford, Briyana Domjahn, Jianguo Xu, Allison Beck, Rebecca Fineman, Shiela Heeke, Jean M. Winter, Shashi Nagar, Colleen F. Kelley, Mark J. Mulligan, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham and 18 more - The Lancet 2017 cited by 304

  21. Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James C. Mullikin, Lawrence Shapiro, Richard A. Koup, Barney S. Graham, Martha Nason, Mark Connors, Barton F. Haynes, Srinivas S. Rao, Mario Roederer, Peter D. Kwong, John R. Mascola, Gary J. Nabel - Journal of Virology 2014 cited by 291

  22. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brenna J. Hill, Rui Kong, Cinque Soto, James C. Mullikin, Daniel C. Douek, David C. Montefiori, Michael A. Moody, George M. Shaw, Beatrice H. Hahn, Garnett Kelsoe, Peter Hraber, Bette Korber, Scott D. Boyd, Andrew Fire, Thomas B. Kepler, Lawrence Shapiro, Andrew B. Ward, John R. Mascola, Hua‐Xin Liao, Peter D. Kwong, Barton F. Haynes - Cell 2016 cited by 341

  23. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lily Zhang, Yunda Huang, Richard A. Koup, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, Floreliz Mendoza, Laura Novik, Kathy Zephir, William Whalen, Brenda Larkin, Jamie Saunders, Jennifer Cunningham, Carol Levinson, Xiaolin Wang, Sarah H. Plummer, Milalynn Victorino, Abidemi Ola, Catina Boyd, Nilusha Jayasinghe, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Olga Vasilenko, Galina V. Yamshchikov, Maria Burgos Florez, Iris Pittman, Lúcio Gama, Joseph P. Casazza, Hope DeCederfelt, KC Cheng, Judy Stein - The Lancet HIV 2019 cited by 107

  24. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Roederer, Mark Connors, Richard A. Koup, Peter D. Kwong, Zhiyong Yang, John R. Mascola, Gary J. Nabel - Science 2017 cited by 271